Menopause can feel like one big balancing act. Between managing your hormone levels and symptoms like hot flashes, night ...

An injection drug known as tirzepatide, already approved by the FDA for treating Type 2 diabetes, is likely to gain approval for weight loss treatment this year. Here's what to know.

Postmenopausal women struggling with weight loss may find a powerful solution by combining the diabetes drug tirzepatide with menopause hormone therapy. A Mayo Clinic study revealed that this dual ...

Pennington Biomedical researchers and their collaborators observed decreased activity in the brain regions responsible for ...

Obesity has become a global epidemic, contributing to a host of chronic health conditions such as type 2 diabetes, hypertension, and cardiovascular ...

Combing a weight-loss drug and hormone therapy may be the key to shedding pounds.

Researchers found that tirzepatide, a medication primarily used for treating type 2 diabetes and weight loss, reduced body ...

Overall, the study found that tirzepatide was more effective at helping participants lose weight. About 82% of participants taking tirzepatide experienced 5% or greater weight loss.

Diabetes drug Mounjaro helped people lose 16% of weight, study finds Two trials have now found tirzepatide, sold under the brand name Mounjaro as a diabetes treatment, to be effective for weight loss.

Tirzepatide 10 mg and 15 mg and semaglutide 2.4 mg outperformed other drugs for weight-loss efficacy. Tirzepatide and semaglutide confer greater weight loss than other FDA-approved obesity ...

SAN ANTONIO — Tirzepatide demonstrated long-term weight-loss benefits and prevention of diabetes progression in patients with obesity and prediabetes, but only so long as they continued the ...

Tirzepatide may be more effective than semaglutide in helping people who have obesity or overweight lose weight, results from a recent study suggest.